Abstract
The recent dramatic development of surgery and anaesthesiology made possible to extend surgical resection for lung cancer (LC) also in patients with important comorbidities. Moreover, the widespread of minimally invasive techniques (VATS procedures) have recently increased the number and the quality of interventions with a limited impact in patients’ postoperative course.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
